148 related articles for article (PubMed ID: 20494673)
1. Does abciximab promote coronary artery remodeling in patients with Kawasaki disease?
McCandless RT; Minich LL; Tani LY; Williams RV
Am J Cardiol; 2010 Jun; 105(11):1625-8. PubMed ID: 20494673
[TBL] [Abstract][Full Text] [Related]
2. Does Abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?
Williams RV; Wilke VM; Tani LY; Minich LL
Pediatrics; 2002 Jan; 109(1):E4. PubMed ID: 11773572
[TBL] [Abstract][Full Text] [Related]
3. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
[TBL] [Abstract][Full Text] [Related]
4. Management of coronary artery aneurysms using abciximab in children with Kawasaki disease.
Bachlava E; Loukopoulou S; Karanasios E; Chrousos G; Michos A
Int J Cardiol; 2016 Oct; 220():65-9. PubMed ID: 27372045
[TBL] [Abstract][Full Text] [Related]
5. Medium-Term Complications Associated With Coronary Artery Aneurysms After Kawasaki Disease: A Study From the International Kawasaki Disease Registry.
McCrindle BW; Manlhiot C; Newburger JW; Harahsheh AS; Giglia TM; Dallaire F; Friedman K; Low T; Runeckles K; Mathew M; Mackie AS; Choueiter NF; Jone PN; Kutty S; Yetman AT; Raghuveer G; Pahl E; Norozi K; McHugh KE; Li JS; De Ferranti SD; Dahdah N;
J Am Heart Assoc; 2020 Aug; 9(15):e016440. PubMed ID: 32750313
[TBL] [Abstract][Full Text] [Related]
6. Predicting Coronary Artery Aneurysms in Kawasaki Disease at a North American Center: An Assessment of Baseline
Son MBF; Gauvreau K; Kim S; Tang A; Dedeoglu F; Fulton DR; Lo MS; Baker AL; Sundel RP; Newburger JW
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28566299
[TBL] [Abstract][Full Text] [Related]
7. [Kawasaki disease in children--9 years experience].
Kowalczyk M; Kawalec W; Daszkowska-York J; Turska-Kmieć A; Brzezińska-Rajszys G; Sobielarska D; Ziółkowska L; Kościesza A; Jagiełłowicz D; Mirecka-Rola A
Med Wieku Rozwoj; 2005; 9(2):179-93. PubMed ID: 16085959
[TBL] [Abstract][Full Text] [Related]
8. Platelet glycoprotein IIb/IIIa receptor blockade therapy for large coronary aneurysms and thrombi in Kawasaki disease.
Etheridge SP; Tani LY; Minich LL; Revenaugh JR
Cathet Cardiovasc Diagn; 1998 Nov; 45(3):264-8. PubMed ID: 9829884
[TBL] [Abstract][Full Text] [Related]
9. Corticosteroid administration for patients with coronary artery aneurysms after Kawasaki disease may be associated with impaired regression.
Millar K; Manlhiot C; Yeung RS; Somji Z; McCrindle BW
Int J Cardiol; 2012 Jan; 154(1):9-13. PubMed ID: 20851480
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.
Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM
Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617
[TBL] [Abstract][Full Text] [Related]
11. Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease.
de Ferranti SD; Gauvreau K; Friedman KG; Tang A; Baker AL; Fulton DR; Tremoulet AH; Burns JC; Newburger JW
JAMA Pediatr; 2018 Dec; 172(12):e183310. PubMed ID: 30285057
[TBL] [Abstract][Full Text] [Related]
12. Effective infliximab therapy for the early regression of coronary artery aneurysm in Kawasaki disease.
Nagatomo Y; Muneuchi J; Nakashima Y; Nanishi E; Shirozu H; Watanabe M; Uike K; Nagata H; Hirata Y; Yamamura K; Takahashi Y; Okada S; Suzuki Y; Hasegawa S; Ohga S
Int J Cardiol; 2018 Nov; 271():317-321. PubMed ID: 30144998
[TBL] [Abstract][Full Text] [Related]
13. Duration of high-dose aspirin therapy does not affect long-term coronary artery outcomes in Kawasaki disease.
Migally K; Braunlin EA; Zhang L; Binstadt BA
Pediatr Res; 2018 Jun; 83(6):1136-1145. PubMed ID: 29554081
[TBL] [Abstract][Full Text] [Related]
14. Successful Treatment of Myocardial Infarction in an Infant With Kawasaki Disease.
Jone PN; Tapia D; Davidson J; Fagan TE; Browne L; Ing RJ; Kay J
Semin Cardiothorac Vasc Anesth; 2015 Sep; 19(3):255-9. PubMed ID: 25700695
[TBL] [Abstract][Full Text] [Related]
15. Time Course of Coronary Artery Aneurysms in Kawasaki Disease.
Tsuda E; Hashimoto S
J Pediatr; 2021 Mar; 230():133-139.e2. PubMed ID: 33301786
[TBL] [Abstract][Full Text] [Related]
16. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
[TBL] [Abstract][Full Text] [Related]
17. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
[TBL] [Abstract][Full Text] [Related]
18. Assessment of coronary artery abnormalities and variability of Z-score calculation in the acute episode of Kawasaki disease-A retrospective study from China.
Liu HH; Qiu Z; Fan GZ; Jiang Q; Li RX; Chen WX; Liu FF; Wu Y; Wang JJ; Wu YF; Luo HH; Zhang DD; Hu P
Eur J Clin Invest; 2021 Mar; 51(3):e13409. PubMed ID: 32916764
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and scores for prediction of coronary artery aneurysms in Kawasaki disease: a European monocentric study.
La Vecchia A; Stracquadaino R; Mauri L; Baselli LA; Abdallah R; Cucchetti M; Colli AM; Agostoni C; Dellepiane RM
BMC Pediatr; 2024 Feb; 24(1):139. PubMed ID: 38395821
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Coronary Arterial Aneurysm Regression in Patients With Kawasaki Disease by Aneurysm Severity: Factors Associated With Regression.
Kato T; Miura M; Kobayashi T; Kaneko T; Fukushima N; Suda K; Maeda J; Shimoyama S; Shiono J; Hirono K; Ikeda K; Sato S; Numano F; Mitani Y; Waki K; Ayusawa M; Fukazawa R; Fuse S;
J Am Heart Assoc; 2023 Feb; 12(3):e022417. PubMed ID: 36718857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
